$90.35−0.01 (−0.01%)
Market open · 15-min delayed · as of 9:44 AM ET
10x Genomics Inc · Overview
Industry: Health Services · see every company filed here →
10x Genomics Inc scores 51/100. Mixed. Strongest on financial health and growth, value is the soft spot versus 489 Technology peers.
Tenet Score · vs sector
n=489Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value19
Quality34
Health86
Growth66
Factor grades
Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityDHealthBGrowthCMomentumA+
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Price
Loading chart…
P/E
—
no P/E on file
P/B
14.8×
cap ÷ fiscal 2025 book value, Sep 30, 2026 close
P/S
18.3×
price to sales
ROE
−6%
return on equity
Operating margin
−9.5%
before interest and tax
Net margin
−6.8%
of revenue kept
Current ratio
4.46
current assets to liabilities
Net debt / EBITDA
—
Withheld: this year's balance sheet carries no debt line while other years of the same company report debt, so its net debt is not known.
EPS CAGR 5y
—
needs five years of positive earnings
Market cap
$11.6B
large cap
Div yield
0.00%
reinvests all
52-wk range
11.16 – 95.16
low → high
Market cap: share price × the latest quarter's diluted weighted-average share count (vendor).
The whole report, at a glance · every card is a live peek, click any to open the section
Tenets
2 / 17
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ~ Drawdown Context
- ~ Reversal Evidence
+11 more →
Financials
Revenue, margins and the five-year statements.Analyst Forecasts
Consensus estimates are on the Analyst tab.
Earnings
Report dates and the beat-versus-miss record.Statistics
ROIC−5%
Gross margin69%
Technical Analysis
Uptrend short-term signalvs 50-day+43.3%
vs 200-day+165.8%
RSI (14)77
News & Insights
Headlines are on the News tab.Dividends
0.00% yield
No dividend. Cash stays in the business.
Ownership
99% institutional
13F flows & insider trades land here.
About 10x Genomics Inc
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium a…
Composite computed 2026-10-01 · peer basis: Technology (n=489) · every glimpse links to its full section with sources · not investment advice.
ETF exposure
Free account: the funds that hold TXG, and at what weight. Everything else on this page stays open.Create a free account